GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Proteome Sciences PLC (LSE:PRM) » Definitions » Debt-to-Revenue

Proteome Sciences (LSE:PRM) Debt-to-Revenue : 2.72 (As of Dec. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Proteome Sciences Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Proteome Sciences's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was £13.23 Mil. Proteome Sciences's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was £1.29 Mil. Proteome Sciences's annualized Revenue for the quarter that ended in Dec. 2024 was £5.34 Mil. Proteome Sciences's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 was 2.72.


Proteome Sciences Debt-to-Revenue Historical Data

The historical data trend for Proteome Sciences's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proteome Sciences Debt-to-Revenue Chart

Proteome Sciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.32 2.28 1.53 2.68 2.97

Proteome Sciences Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.31 1.76 3.71 3.07 2.72

Competitive Comparison of Proteome Sciences's Debt-to-Revenue

For the Diagnostics & Research subindustry, Proteome Sciences's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Proteome Sciences's Debt-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Proteome Sciences's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Proteome Sciences's Debt-to-Revenue falls into.


;
;

Proteome Sciences Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Proteome Sciences's Debt-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(13.233 + 1.289) / 4.887
=2.97

Proteome Sciences's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(13.233 + 1.289) / 5.34
=2.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Dec. 2024) Revenue data.


Proteome Sciences Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Proteome Sciences's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Proteome Sciences Business Description

Traded in Other Exchanges
Address
Downside Bridge Road, Coveham House, Cobham, Surrey, GBR, KT11 3EP
Proteome Sciences PLC is protein biomarker research and development. provider of contract research services for the identification, validation and application of protein biomarkers. Its only reportable segment is the sale of goods and biomarker services. It generates maximum revenue from the TMT product and end customer sales-based royalties. Geographically, it has a presence in the United States, the United Kingdom, the European Union, and Other.